| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DEMANT.CO - | SELL | -85 @ DKK 28.4824 | DKK -2,421 | The ETF sold 85 shares of DEMANT.CO on 2025-12-18. The shares were previously bought for an average price of DKK 32.2794. The shares were sold for -11.8% lower than average price of previous purchases. This resulted in an overall loss of DKK 323 (USD $51) The average price that the ETF previously sold DEMANT.CO share for is DKK 33.6658 which is higher than the selling price of DKK 28.4824 on 2025-12-18. |
| HIK.L - | SELL | -147 @ GBP 17.2465 | GBP -2,535 | The ETF sold 147 shares of HIK.L on 2025-12-18. The shares were previously bought for an average price of GBP 22.3835. The shares were sold for -22.9% lower than average price of previous purchases. This resulted in an overall loss of GBP 755 (USD $1,010) The average price that the ETF previously sold HIK.L share for is GBP 22.4805 which is higher than the selling price of GBP 17.2465 on 2025-12-18. |
| GRF.MC - Grifols SA | SELL | -261 @ EUR 10.795 | EUR -2,817 | The ETF sold 261 shares of GRF.MC on 2025-12-18. The shares were previously bought for an average price of EUR 10.6752. The Grifols SA shares were sold for 1.1% higher than average price of previous purchases. This sale made a profit of EUR 31 (USD $37) The average price that the ETF previously sold GRF.MC share for is EUR 10.4419 so the ETF has sold 261 shares on 2025-12-18 at a higher price than the previous selling average. |
| TUB.BR - Financiere de Tubize SA | SELL | -18 @ EUR 209.5 | EUR -3,771 | The ETF sold 18 shares of TUB.BR on 2025-12-18. The shares were previously bought for an average price of EUR 210.25. The Financiere de Tubize SA shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of EUR 14 (USD $16) The average price that the ETF previously sold TUB.BR share for is EUR 218.021 which is higher than the selling price of EUR 209.5 on 2025-12-18. |
| BIM.PA - BioMerieux | SELL | -36 @ EUR 108.5 | EUR -3,906 | The ETF sold 36 shares of BIM.PA on 2025-12-18. The shares were previously bought for an average price of EUR 114.199. The BioMerieux shares were sold for -5.0% lower than average price of previous purchases. This resulted in an overall loss of EUR 205 (USD $241) The average price that the ETF previously sold BIM.PA share for is EUR 110.538 which is higher than the selling price of EUR 108.5 on 2025-12-18. |
| IPN.PA - Ipsen SA | SELL | -33 @ EUR 120.1 | EUR -3,963 | The ETF sold 33 shares of IPN.PA on 2025-12-18. The shares were previously bought for an average price of EUR 110.554. The Ipsen SA shares were sold for 8.6% higher than average price of previous purchases. This sale made a profit of EUR 315 (USD $370) The average price that the ETF previously sold IPN.PA share for is EUR 110.044 so the ETF has sold 33 shares on 2025-12-18 at a higher price than the previous selling average. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | SELL | -101 @ EUR 48.56 | EUR -4,905 | The ETF sold 101 shares of REC.MI on 2025-12-18. The shares were previously bought for an average price of EUR 52.7383. The Recordati Industria Chimica e Farmaceutica SpA shares were sold for -7.9% lower than average price of previous purchases. This resulted in an overall loss of EUR 422 (USD $496) The average price that the ETF previously sold REC.MI share for is EUR 50.805 which is higher than the selling price of EUR 48.56 on 2025-12-18. |
| SOBI.ST - | SELL | -173 @ SEK 29.7701 | SEK -5,150 | The ETF sold 173 shares of SOBI.ST on 2025-12-18. The shares were previously bought for an average price of SEK 26.7864. The shares were sold for 11.1% higher than average price of previous purchases. This sale made a profit of SEK 516 (USD $56) The average price that the ETF previously sold SOBI.ST share for is SEK 27.6718 so the ETF has sold 173 shares on 2025-12-18 at a higher price than the previous selling average. |
| DIM.PA - Sartorius Stedim Biotech | SELL | -26 @ EUR 203.7 | EUR -5,296 | The ETF sold 26 shares of DIM.PA on 2025-12-18. The shares were previously bought for an average price of EUR 192.964. The Sartorius Stedim Biotech shares were sold for 5.6% higher than average price of previous purchases. This sale made a profit of EUR 279 (USD $328) The average price that the ETF previously sold DIM.PA share for is EUR 193.684 so the ETF has sold 26 shares on 2025-12-18 at a higher price than the previous selling average. |
| SRT3.DE - Sartorius AG | SELL | -23 @ EUR 237.5 | EUR -5,463 | The ETF sold 23 shares of SRT3.DE on 2025-12-18. The shares were previously bought for an average price of EUR 217.069. The Sartorius AG shares were sold for 9.4% higher than average price of previous purchases. This sale made a profit of EUR 470 (USD $552) The average price that the ETF previously sold SRT3.DE share for is EUR 227.679 so the ETF has sold 23 shares on 2025-12-18 at a higher price than the previous selling average. |
| ORNBV.HE - Orion Oyj | SELL | -96 @ EUR 61.3 | EUR -5,885 | The ETF sold 96 shares of ORNBV.HE on 2025-12-18. The shares were previously bought for an average price of EUR 59.669. The Orion Oyj shares were sold for 2.7% higher than average price of previous purchases. This sale made a profit of EUR 157 (USD $184) The average price that the ETF previously sold ORNBV.HE share for is EUR 55.3356 so the ETF has sold 96 shares on 2025-12-18 at a higher price than the previous selling average. |
| ERF.PA - Eurofins Scientific SE | SELL | -104 @ EUR 61.66 | EUR -6,413 | The ETF sold 104 shares of ERF.PA on 2025-12-18. The shares were previously bought for an average price of EUR 57.6515. The Eurofins Scientific SE shares were sold for 7.0% higher than average price of previous purchases. This sale made a profit of EUR 417 (USD $490) The average price that the ETF previously sold ERF.PA share for is EUR 53.9493 so the ETF has sold 104 shares on 2025-12-18 at a higher price than the previous selling average. |
| QIA.DE - QIAGEN NV | SELL | -191 @ EUR 38.445 | EUR -7,343 | The ETF sold 191 shares of QIA.DE on 2025-12-18. The shares were previously bought for an average price of EUR 39.6413. The QIAGEN NV shares were sold for -3.0% lower than average price of previous purchases. This resulted in an overall loss of EUR 228 (USD $268) The average price that the ETF previously sold QIA.DE share for is EUR 38.6567 which is higher than the selling price of EUR 38.445 on 2025-12-18. |
| FME.DE - Fresenius Medical Care AG | SELL | -194 @ EUR 40.28 | EUR -7,814 | The ETF sold 194 shares of FME.DE on 2025-12-18. The shares were previously bought for an average price of EUR 45.9708. The Fresenius Medical Care AG shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of EUR 1,104 (USD $1,296) The average price that the ETF previously sold FME.DE share for is EUR 45.4593 which is higher than the selling price of EUR 40.28 on 2025-12-18. |
| COLO-B.CO - | SELL | -111 @ DKK 72.7319 | DKK -8,073 | The ETF sold 111 shares of COLO-B.CO on 2025-12-18. The shares were previously bought for an average price of DKK 83.2028. The shares were sold for -12.6% lower than average price of previous purchases. This resulted in an overall loss of DKK 1,162 (USD $183) The average price that the ETF previously sold COLO-B.CO share for is DKK 85.3884 which is higher than the selling price of DKK 72.7319 on 2025-12-18. |
| RO.SW - | SELL | -28 @ CHF 354.41 | CHF -9,923 | The ETF sold 28 shares of RO.SW on 2025-12-18. The shares were previously bought for an average price of CHF 304.239. The shares were sold for 16.5% higher than average price of previous purchases. This sale made a profit of CHF 1,405 (USD $1,767) The average price that the ETF previously sold RO.SW share for is CHF 306.588 so the ETF has sold 28 shares on 2025-12-18 at a higher price than the previous selling average. |
| STMN.SW - | SELL | -98 @ CHF 101.404 | CHF -9,938 | The ETF sold 98 shares of STMN.SW on 2025-12-18. The shares were previously bought for an average price of CHF 109.888. The shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of CHF 831 (USD $1,046) The average price that the ETF previously sold STMN.SW share for is CHF 112.471 which is higher than the selling price of CHF 101.404 on 2025-12-18. |
| SN.L - Smith & Nephew PLC | SELL | -708 @ GBP 14.0542 | GBP -9,950 | The ETF sold 708 shares of SN.L on 2025-12-18. The shares were previously bought for an average price of GBP 13.6992. The Smith & Nephew PLC shares were sold for 2.6% higher than average price of previous purchases. This sale made a profit of GBP 251 (USD $336) The average price that the ETF previously sold SN.L share for is GBP 13.2054 so the ETF has sold 708 shares on 2025-12-18 at a higher price than the previous selling average. |
| SOON.SW - | SELL | -45 @ CHF 221.775 | CHF -9,980 | The ETF sold 45 shares of SOON.SW on 2025-12-18. The shares were previously bought for an average price of CHF 260.436. The shares were sold for -14.8% lower than average price of previous purchases. This resulted in an overall loss of CHF 1,740 (USD $2,188) The average price that the ETF previously sold SOON.SW share for is CHF 281.182 which is higher than the selling price of CHF 221.775 on 2025-12-18. |
| SHL.DE - Siemens Healthineers AG | SELL | -298 @ EUR 44.72 | EUR -13,327 | The ETF sold 298 shares of SHL.DE on 2025-12-18. The shares were previously bought for an average price of EUR 47.1994. The Siemens Healthineers AG shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of EUR 739 (USD $868) The average price that the ETF previously sold SHL.DE share for is EUR 47.9875 which is higher than the selling price of EUR 44.72 on 2025-12-18. |
| MRK.DE - Merck KGaA | SELL | -114 @ EUR 118.85 | EUR -13,549 | The ETF sold 114 shares of MRK.DE on 2025-12-18. The shares were previously bought for an average price of EUR 117.731. The Merck KGaA shares were sold for 1.0% higher than average price of previous purchases. This sale made a profit of EUR 128 (USD $150) The average price that the ETF previously sold MRK.DE share for is EUR 123.131 which is higher than the selling price of EUR 118.85 on 2025-12-18. |
| GMAB.CO - | SELL | -54 @ DKK 268.227 | DKK -14,484 | The ETF sold 54 shares of GMAB.CO on 2025-12-18. The shares were previously bought for an average price of DKK 209.088. The shares were sold for 28.3% higher than average price of previous purchases. This sale made a profit of DKK 3,194 (USD $502) The average price that the ETF previously sold GMAB.CO share for is DKK 206.145 so the ETF has sold 54 shares on 2025-12-18 at a higher price than the previous selling average. |
| PHIA.AS - Koninklijke Philips NV | SELL | -678 @ EUR 22.79 | EUR -15,452 | The ETF sold 678 shares of PHIA.AS on 2025-12-18. The shares were previously bought for an average price of EUR 22.3589. The Koninklijke Philips NV shares were sold for 1.9% higher than average price of previous purchases. This sale made a profit of EUR 292 (USD $343) The average price that the ETF previously sold PHIA.AS share for is EUR 23.0974 which is higher than the selling price of EUR 22.79 on 2025-12-18. |
| FRE.DE - Fresenius SE & Co KGaA | SELL | -372 @ EUR 47.92 | EUR -17,826 | The ETF sold 372 shares of FRE.DE on 2025-12-18. The shares were previously bought for an average price of EUR 42.6885. The Fresenius SE & Co KGaA shares were sold for 12.3% higher than average price of previous purchases. This sale made a profit of EUR 1,946 (USD $2,285) The average price that the ETF previously sold FRE.DE share for is EUR 41.2884 so the ETF has sold 372 shares on 2025-12-18 at a higher price than the previous selling average. |
| SDZ.SW - | SELL | -368 @ CHF 62.3762 | CHF -22,954 | The ETF sold 368 shares of SDZ.SW on 2025-12-18. The shares were previously bought for an average price of CHF 46.9107. The shares were sold for 33.0% higher than average price of previous purchases. This sale made a profit of CHF 5,691 (USD $7,157) The average price that the ETF previously sold SDZ.SW share for is CHF 46.6368 so the ETF has sold 368 shares on 2025-12-18 at a higher price than the previous selling average. |
| GALD.SW - | SELL | -136 @ CHF 176.99 | CHF -24,071 | The ETF sold 136 shares of GALD.SW on 2025-12-18. The shares were previously bought for an average price of CHF 132.226. The shares were sold for 33.9% higher than average price of previous purchases. This sale made a profit of CHF 6,088 (USD $7,656) The average price that the ETF previously sold GALD.SW share for is CHF 128.814 so the ETF has sold 136 shares on 2025-12-18 at a higher price than the previous selling average. |
| UCB.BR - UCB SA | SELL | -111 @ EUR 236.4 | EUR -26,240 | The ETF sold 111 shares of UCB.BR on 2025-12-18. The shares were previously bought for an average price of EUR 189.972. The UCB SA shares were sold for 24.4% higher than average price of previous purchases. This sale made a profit of EUR 5,154 (USD $6,051) The average price that the ETF previously sold UCB.BR share for is EUR 187.663 so the ETF has sold 111 shares on 2025-12-18 at a higher price than the previous selling average. |
| ALC.SW - | SELL | -440 @ CHF 68.3905 | CHF -30,092 | The ETF sold 440 shares of ALC.SW on 2025-12-18. The shares were previously bought for an average price of CHF 73.8693. The shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of CHF 2,411 (USD $3,032) The average price that the ETF previously sold ALC.SW share for is CHF 77.1119 which is higher than the selling price of CHF 68.3905 on 2025-12-18. |
| BAYN.DE - Bayer AG | SELL | -865 @ EUR 35.3 | EUR -30,534 | The ETF sold 865 shares of BAYN.DE on 2025-12-18. The shares were previously bought for an average price of EUR 25.5091. The Bayer AG shares were sold for 38.4% higher than average price of previous purchases. This sale made a profit of EUR 8,469 (USD $9,945) The average price that the ETF previously sold BAYN.DE share for is EUR 24.7332 so the ETF has sold 865 shares on 2025-12-18 at a higher price than the previous selling average. |
| HLN.L - Haleon PLC | SELL | -7,823 @ GBP 4.23053 | GBP -33,095 | The ETF sold 7823 shares of HLN.L on 2025-12-18. The shares were previously bought for an average price of GBP 4.39824. The Haleon PLC shares were sold for -3.8% lower than average price of previous purchases. This resulted in an overall loss of GBP 1,312 (USD $1,755) The average price that the ETF previously sold HLN.L share for is GBP 4.45773 which is higher than the selling price of GBP 4.23053 on 2025-12-18. |
| LONN.SW - | SELL | -62 @ CHF 569.419 | CHF -35,304 | The ETF sold 62 shares of LONN.SW on 2025-12-18. The shares were previously bought for an average price of CHF 603.713. The shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of CHF 2,126 (USD $2,674) The average price that the ETF previously sold LONN.SW share for is CHF 585.312 which is higher than the selling price of CHF 569.419 on 2025-12-18. |
| ARGX.BR - Argenx SE | SELL | -54 @ EUR 728 | EUR -39,312 | The ETF sold 54 shares of ARGX.BR on 2025-12-18. The shares were previously bought for an average price of EUR 585.67. The Argenx SE shares were sold for 24.3% higher than average price of previous purchases. This sale made a profit of EUR 7,686 (USD $9,025) The average price that the ETF previously sold ARGX.BR share for is EUR 598.08 so the ETF has sold 54 shares on 2025-12-18 at a higher price than the previous selling average. |
| EL.PA - EssilorLuxottica SA | SELL | -264 @ EUR 276.3 | EUR -72,943 | The ETF sold 264 shares of EL.PA on 2025-12-18. The shares were previously bought for an average price of EUR 263.173. The EssilorLuxottica SA shares were sold for 5.0% higher than average price of previous purchases. This sale made a profit of EUR 3,466 (USD $4,069) The average price that the ETF previously sold EL.PA share for is EUR 262.885 so the ETF has sold 264 shares on 2025-12-18 at a higher price than the previous selling average. |
| GSK.L - GlaxoSmithKline PLC | SELL | -3,570 @ GBP 20.7015 | GBP -73,904 | The ETF sold 3570 shares of GSK.L on 2025-12-18. The shares were previously bought for an average price of GBP 17.4295. The GlaxoSmithKline PLC shares were sold for 18.8% higher than average price of previous purchases. This sale made a profit of GBP 11,681 (USD $15,623) The average price that the ETF previously sold GSK.L share for is GBP 17.5166 so the ETF has sold 3570 shares on 2025-12-18 at a higher price than the previous selling average. |
| SAN.PA - Sanofi SA | SELL | -970 @ EUR 82.1 | EUR -79,637 | The ETF sold 970 shares of SAN.PA on 2025-12-18. The shares were previously bought for an average price of EUR 87.044. The Sanofi SA shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of EUR 4,796 (USD $5,631) The average price that the ETF previously sold SAN.PA share for is EUR 90.7874 which is higher than the selling price of EUR 82.1 on 2025-12-18. |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -2,829 @ DKK 40.7293 | DKK -115,223 | The ETF sold 2829 shares of NOVO-B.CO on 2025-12-18. The shares were previously bought for an average price of DKK 54.3016. The Novo Nordisk A/S shares were sold for -25.0% lower than average price of previous purchases. This resulted in an overall loss of DKK 38,396 (USD $6,035) The average price that the ETF previously sold NOVO-B.CO share for is DKK 53.0544 which is higher than the selling price of DKK 40.7293 on 2025-12-18. |
| NOVN.SW - | SELL | -1,670 @ CHF 115.71 | CHF -193,236 | The ETF sold 1670 shares of NOVN.SW on 2025-12-18. The shares were previously bought for an average price of CHF 104.297. The shares were sold for 10.9% higher than average price of previous purchases. This sale made a profit of CHF 19,060 (USD $23,967) The average price that the ETF previously sold NOVN.SW share for is CHF 102.606 so the ETF has sold 1670 shares on 2025-12-18 at a higher price than the previous selling average. |
| AZN.L - AstraZeneca PLC | SELL | -1,362 @ GBP 154.739 | GBP -210,755 | The ETF sold 1362 shares of AZN.L on 2025-12-18. The shares were previously bought for an average price of GBP 132.331. The AstraZeneca PLC shares were sold for 16.9% higher than average price of previous purchases. This sale made a profit of GBP 30,520 (USD $40,819) The average price that the ETF previously sold AZN.L share for is GBP 132.673 so the ETF has sold 1362 shares on 2025-12-18 at a higher price than the previous selling average. |
| ROG.SW - | SELL | -617 @ CHF 343.134 | CHF -211,714 | The ETF sold 617 shares of ROG.SW on 2025-12-18. The shares were previously bought for an average price of CHF 288.914. The shares were sold for 18.8% higher than average price of previous purchases. This sale made a profit of CHF 33,454 (USD $42,070) The average price that the ETF previously sold ROG.SW share for is CHF 291.563 so the ETF has sold 617 shares on 2025-12-18 at a higher price than the previous selling average. |